Other News

Physiomics have now added both posters presented by Dr Fernando Ortega and Dr Claire Villette at the AACR conference, Atlanta to their website. To view 'A Precision Dosing Application For Advanced Prostate Cancer Chemotherapy' please click here and for 'Modelling the effect of Radiotherapy on tumour growth inhibition: the head and neck tumour case' please click here....

Dr Hitesh Mistry, Principal Consultant for Physiomics was interviewed by BioNeex on Cancer drug licensing: How to use your data to make yourself an attractive partner. Please click here to watch the interview in full....

Physiomics plc (AIM: PYC), is pleased to announce that one of its long-term consultants and collaborators, Dr Hitesh Mistry, has been appointed to the editorial board of the International Journal of Radiation Oncology-Biology-Physics (RedJournal). Click here to read in full....

Physiomics' cutting edge technology is starting to catch the attention of the world of oncology according to this article in the Daily Mail...

Physiomics plc is pleased to announce that it will be attending the 30th EORTC-NCI-AACR SYMPOSIUM in Dublin 13-16 November 2018. The European Organisation for Research and Treatment of Cancer (“EORTC”) acts as a hub for a network of over 930 institutions in 30 countries focused on translational and clinical cancer research. The Symposium is co-hosted by EORTC, the National Cancer Institute (NCI) and the American Association for...

Dr Jim Millen, CEO of Physiomics, talks to Proactive Investors’ Andrew Scott about recent successes and the company’s future direction. Please click here to watch video....

Physiomics consultant and senior advisor, Dr David Orrell, will give one of the keynote speeches at the 38th International Symposium on Forecasting, Colorado USA on 17th June.   The conference is the premiere international event focused on forecasting across a spectrum of social and scientific disciplines. The event is organised by the International Institute of Forecasters (IIF), which promotes best practices and advancing the field of forecasting through...

Dr Jim Millen, CEO of Physiomics, talks to Proactive Investors’ Andrew Scott about recent successes and the company’s future direction. Please click here to watch video....

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it will attend BioTrinity 2018.  BioTrinity is one of Europe’s leading biopartnering and investment conferences, to be held on 23-25 April at the Novotel London West. Click here to read more....

We have an opportunity for a Biosimulation Scientist to join our technical team to work on projects related to drug development. Find more details at our careers page....